rs4280427

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003642.4(HAT1):​c.309+3691G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.425 in 151,782 control chromosomes in the GnomAD database, including 15,297 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 15297 hom., cov: 33)

Consequence

HAT1
NM_003642.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.469

Publications

7 publications found
Variant links:
Genes affected
HAT1 (HGNC:4821): (histone acetyltransferase 1) The protein encoded by this gene is a type B histone acetyltransferase (HAT) that is involved in the rapid acetylation of newly synthesized cytoplasmic histones, which are in turn imported into the nucleus for de novo deposition onto nascent DNA chains. Histone acetylation, particularly of histone H4, plays an important role in replication-dependent chromatin assembly. Specifically, this HAT can acetylate soluble but not nucleosomal histone H4 at lysines 5 and 12, and to a lesser degree, histone H2A at lysine 5. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jun 2009]
SLC25A12 (HGNC:10982): (solute carrier family 25 member 12) This gene encodes a calcium-binding mitochondrial carrier protein. The encoded protein localizes to the mitochondria and is involved in the exchange of aspartate for glutamate across the inner mitochondrial membrane. Polymorphisms in this gene may be associated with autism, and mutations in this gene may also be a cause of global cerebral hypomyelination. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
SLC25A12 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 39
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003642.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.539 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003642.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAT1
NM_003642.4
MANE Select
c.309+3691G>A
intron
N/ANP_003633.2O14929-1
HAT1
NR_027862.2
n.273+3691G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAT1
ENST00000264108.5
TSL:1 MANE Select
c.309+3691G>A
intron
N/AENSP00000264108.4O14929-1
HAT1
ENST00000412731.5
TSL:1
n.*92+3691G>A
intron
N/AENSP00000407921.1F8WEW1
HAT1
ENST00000457761.6
TSL:1
n.189-8646G>A
intron
N/AENSP00000403466.2F8W9G7

Frequencies

GnomAD3 genomes
AF:
0.426
AC:
64567
AN:
151662
Hom.:
15307
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.239
Gnomad AMI
AF:
0.469
Gnomad AMR
AF:
0.377
Gnomad ASJ
AF:
0.517
Gnomad EAS
AF:
0.136
Gnomad SAS
AF:
0.551
Gnomad FIN
AF:
0.515
Gnomad MID
AF:
0.586
Gnomad NFE
AF:
0.543
Gnomad OTH
AF:
0.455
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.425
AC:
64555
AN:
151782
Hom.:
15297
Cov.:
33
AF XY:
0.425
AC XY:
31545
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.238
AC:
9877
AN:
41458
American (AMR)
AF:
0.376
AC:
5747
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.517
AC:
1790
AN:
3464
East Asian (EAS)
AF:
0.136
AC:
705
AN:
5172
South Asian (SAS)
AF:
0.550
AC:
2646
AN:
4810
European-Finnish (FIN)
AF:
0.515
AC:
5400
AN:
10480
Middle Eastern (MID)
AF:
0.582
AC:
171
AN:
294
European-Non Finnish (NFE)
AF:
0.543
AC:
36842
AN:
67820
Other (OTH)
AF:
0.452
AC:
953
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1774
3548
5322
7096
8870
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.496
Hom.:
28513
Bravo
AF:
0.404
Asia WGS
AF:
0.333
AC:
1161
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
4.1
DANN
Benign
0.86
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4280427;
hg19: chr2-172813218;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.